These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6460129)

  • 1. [Serological and immunological study of beta 1H globulin (author's transl)].
    Tochihara K
    Nihon Jinzo Gakkai Shi; 1981 Apr; 23(4):389-98. PubMed ID: 6460129
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of beta 1H globulin in pemphigus, bullous pemphigoid and dermatitis herpetiformis (author's transl)].
    Sugiura M
    Nihon Hifuka Gakkai Zasshi; 1982 May; 92(6):629-34. PubMed ID: 6213797
    [No Abstract]   [Full Text] [Related]  

  • 3. Demonstration of beta 1H globulin in pemphigus.
    Nishikawa T; Sugiura M; Hashimoto T; Kurihara S; Tamura N
    Acta Derm Venereol; 1983; 63(1):39-41. PubMed ID: 6191487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deposition of beta 1H globulin in kidneys of patients with immune renal disease.
    Carlo JR; Ruddy S; Sauter S; Yount WJ
    Arthritis Rheum; 1979 Apr; 22(4):403-11. PubMed ID: 85452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
    Whaley K; Schur PH; Ruddy S
    Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for glomerular modulation of complement activation.
    Moseley HL; Whaley K
    J Clin Lab Immunol; 1979 Apr; 2(1):9-13. PubMed ID: 95813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunological and clinical study of the immunoconglutinins in renal diseases (author's transl)].
    Seki M
    Nihon Jinzo Gakkai Shi; 1980 Oct; 22(10):1249-58. PubMed ID: 7241850
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.
    Aguado MT; Perrin LH; Ramirez R; Miescher PA; Lambert PH
    Clin Exp Immunol; 1980 Dec; 42(3):495-505. PubMed ID: 6163579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of beta 1H globulin together with C3 in the dermal-epidermal junction of patients with systemic lupus erythematosus.
    Carlo JR; Rothfield NF; Ruddy S
    Arthritis Rheum; 1979 Jan; 22(1):13-8. PubMed ID: 83148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of the lupus band test in systemic lupus erythematosus (author's transl)].
    Yasue T
    Nihon Hifuka Gakkai Zasshi; 1980 Sep; 90(10):901-7. PubMed ID: 7012400
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinicopathological study of lupus nephritis: significance of antinative DNA antibody (author's transl)].
    Asano Y
    Nihon Naika Gakkai Zasshi; 1977 Dec; 66(12):1707-18. PubMed ID: 344816
    [No Abstract]   [Full Text] [Related]  

  • 12. Double immunofluorescence studies of immunoglobulins, complement components and their control proteins in patients with IgA nephropathy.
    Tomino Y; Endoh M; Nomoto Y; Sakai H
    Acta Pathol Jpn; 1982 Mar; 32(2):251-6. PubMed ID: 6211893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin.
    Lambris JD; Dobson NJ; Ross GD
    J Exp Med; 1980 Dec; 152(6):1625-44. PubMed ID: 6450259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A circulating inhibitor of fluid-phase amplification. C3 convertase formation in systemic lupus erythematosus.
    Waldo FB; Forristal J; Beischel L; West CD
    J Clin Invest; 1985 Jun; 75(6):1786-95. PubMed ID: 3159752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of serum C3 levels by beta 1H and C3b inactivator.
    Wyatt RJ; Forristal J; Davis CA; Coleman TH; West CD
    J Lab Clin Med; 1980 Jun; 95(6):905-17. PubMed ID: 6445926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-DNA antibodies in systemic lupus erythematosus (author's transl)].
    Clotet B; Ruibal A; Pigrau C; Murcia C; Pahissa A; Lience E
    Med Clin (Barc); 1982 Feb; 78(4):128-131. PubMed ID: 6978438
    [No Abstract]   [Full Text] [Related]  

  • 17. Deposition of C4-binding protein and beta 1H globulin in kidneys of patients with IgA nephropathy.
    Tomino Y; Sakai H; Nomoto Y; Endoh M; Arimori S; Fujita T
    Tokai J Exp Clin Med; 1981 Apr; 6(2):217-22. PubMed ID: 6458121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alternative complement pathway (author's transl)].
    Kazatchkine M; Nydegger U; Fearon DT
    Nouv Presse Med; 1979 Jun; 8(26):2187-94. PubMed ID: 382108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta 1C-globulin in child nephropathies].
    Borgeaud M; Paunier L; Humair LM
    Helv Paediatr Acta; 1970 Dec; 25(6):585-601. PubMed ID: 4102394
    [No Abstract]   [Full Text] [Related]  

  • 20. Glomerular and dermal deposition of properdin in systemic lupus erythematosus.
    Rothfield N; Ross HA; Minta JO; Lepow IH
    N Engl J Med; 1972 Oct; 287(14):681-5. PubMed ID: 4115613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.